Skip to main content

No-Drain Policy Noninferior for Major Morbidity in Distal Pancreatectomy

Medically reviewed by Carmen Pope, BPharm. Last updated on April 1, 2024.

By Elana Gotkine HealthDay Reporter

MONDAY, April 1, 2024 -- For patients with distal pancreatectomy, a no-drain policy is noninferior in terms of major morbidity, according to a study published online March 15 in The Lancet Gastroenterology and Hepatology.

Eduard A. van Bodegraven, M.D., from the University of Amsterdam, and colleagues examined the noninferiority of a no-drain policy in patients with distal pancreatectomy in a multicenter, randomized, noninferiority trial. Patients undergoing open or minimally invasive elective distal pancreatectomy for all indications were randomly assigned intraoperatively to no drain or prophylactic passive drain placement (138 and 144, respectively). Seven patients in the no-drain group received a drain intraoperatively, resulting in a per-protocol population of 131 and 144, respectively.

The researchers found that in the intention-to-treat analysis, the rate of major morbidity was noninferior in the no-drain versus the drain group (15 versus 20 percent); similar results were seen in the per-protocol analysis (16 versus 20 percent). In the intention-to-treat analysis, grade B or C postoperative pancreatic fistula occurred in 12 and 27 percent of patients in the no-drain and drain groups, respectively. Three patients in the no-drain group died within 90 days; two deaths were unrelated to the trial. Within 90 days, no patients from the drain group died.

"We expect these results to be practice-changing and encourage the implementation of a no-drain policy as the new standard approach in eligible patients undergoing distal pancreatectomy," the authors write.

Several authors disclosed ties to medical device companies, including Ethicon, which funded the study.

Abstract/Full Text (subscription or payment may be required)

Editorial (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted April 2024

Read this next

For Women With Obesity, Risk for Breast Cancer Drops After Bariatric Surgery

THURSDAY, May 16, 2024 -- For women with obesity, the risk for breast cancer is reduced after bariatric surgery, according to a study published online May 15 in JAMA...

Bariatric Surgery Tied to Higher Short-Term Risk for Venous Thromboembolism

THURSDAY, May 9, 2024 -- In the short term, bariatric surgery is associated with a greater risk for venous thromboembolism (VTE), but in the long-term, it is associated with lower...

Bariatric Arterial Embolization Safe, Effective in Patients With Severe Obesity

TUESDAY, April 2, 2024 -- Bariatric arterial embolization (BAE) is feasible, effective, and well tolerated among patients with severe obesity, according to a study presented at...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.